| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56449a26d4db6d1825dd063330ed960c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A24B15-16 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A24B15-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A24B15-301
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A24B15-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A24B15-303
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A24B15-281
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A24B13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A24B15-403
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A24B15-308 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A24B15-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A24B15-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A24B13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A24B15-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A24B15-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A24B15-28 |
| filingDate |
2019-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cec09898e7e0defb157ceab5dbe3d120
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_144398341eb7444f8cb883760cedca69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c43c4f10df5bbfced786301090d6273e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_267fa228c2dab96f608ec4ce7f051550
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f09bba156242717eb6c0d27f8a0c7f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbcda37a89a7cde92ff47683dd3f31ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48421c43ebb89afd34db028aedbba285 |
| publicationDate |
2021-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2021169124-A1 |
| titleOfInvention |
Oral products with improved binding of active ingredients |
| abstract |
The disclosure provides products configured for oral use, the products including compositions comprising a filler component including negatively charged groups and an active ingredient including positively charged groups. The active ingredient can be retained by the filler component at least in part through bonding between the negatively charged groups and the positively charged groups such that active ingredient may be release from the product when positioned within an oral cavity of a consumer. |
| priorityDate |
2019-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |